Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 07, 2013

GLAXOSMITHKLINE LLC v. TEVA PHARMACEUTICALS USA, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 24, 2014

    GSK Blasts Teva's Use Of Pom Ruling To Nix False-Ad Suit

    GlaxoSmithKline LLC criticized Teva Pharmaceuticals USA Inc.'s request for reconsideration of a Pennsylvania federal judge's refusal to dismiss GSK's suit, which accuses Teva of falsely advertising a generic antidepressant as equivalent to Wellbutrin, arguing Tuesday that Teva misinterpreted Pom Wonderful.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login